Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aartidrugs.com | |
Market Cap | 4,485.51 Cr. | |
Enterprise Value(EV) | 5,072.68 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 19.60 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 24.89 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 131.55 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.71 | Calculated using Price: 487.90 |
Dividend Yield | 0.21 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.19 Cr. | 91,935,000 Shares |
FaceValue | 10 | |
About Aarti Drugs Ltd. | ||
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries. |
1 Day |
|
-0.50% |
1 Week |
|
+0.40% |
1 Month |
|
+3.80% |
3 Month |
|
-20.71% |
6 Month |
|
+3.56% |
1 Year |
|
+6.75% |
2 Year |
|
-8.21% |
5 Year |
|
+246.79% |
10 Year |
|
+1888.99% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 32.78 | 20.65 | 21.60 | 19.24 | 17.97 | 23.65 | 35.81 | 21.03 | 14.93 | |
Return on Capital Employed (%) | 23.93 | 17.95 | 18.14 | 17.31 | 17.01 | 21.39 | 34.52 | 20.75 | 15.49 | |
Return on Assets (%) | 10.13 | 6.53 | 7.13 | 6.38 | 6.31 | 9.33 | 16.78 | 10.32 | 7.19 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 308 | 357 | 400 | 455 | 543 | 652 | 913 | 1,036 | 1,192 | 1,209 | |
Non Curr. Liab. | 211 | 244 | 297 | 312 | 321 | 301 | 257 | 232 | 296 | 309 | |
Curr. Liab. | 483 | 501 | 494 | 622 | 591 | 623 | 595 | 940 | 933 | 833 | |
Minority Int. | 0 | 0 | 0 | 0 | |||||||
Equity & Liab. | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 | 2,352 | |
Non Curr. Assets | 476 | 537 | 620 | 653 | 671 | 673 | 709 | 815 | 929 | 1,014 | |
Curr. Assets | 526 | 565 | 571 | 737 | 784 | 904 | 1,057 | 1,393 | 1,492 | 1,338 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 | 2,352 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,097 | 1,140 | 1,195 | 1,244 | 1,561 | 1,806 | 2,155 | 2,489 | 2,716 | 2,709 | |
Other Income | 1 | 4 | 1 | 2 | 1 | 5 | 11 | 2 | 3 | ||
Total Income | 1,098 | 1,140 | 1,199 | 1,245 | 1,563 | 1,808 | 2,159 | 2,500 | 2,718 | 2,712 | |
Total Expenditure | -925 | -960 | -1,005 | -1,042 | -1,350 | -1,541 | -1,714 | -2,156 | -2,407 | -2,384 | |
PBIDT | 173 | 180 | 194 | 203 | 213 | 267 | 445 | 344 | 312 | 328 | |
Interest | -42 | -48 | -40 | -38 | -44 | -37 | -26 | -24 | -37 | -35 | |
Depreciation | -31 | -37 | -38 | -40 | -43 | -49 | -50 | -50 | -50 | -50 | |
Taxation | -22 | -27 | -34 | -42 | -41 | -44 | -89 | -65 | -58 | -62 | |
Exceptional Items | 4 | 4 | 0 | ||||||||
PAT | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | 180 | |
Minority Interest | 0 | 0 | 0 | 0 | |||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | 180 | |
Adjusted EPS | 8 | 7 | 9 | 9 | 10 | 15 | 30 | 22 | 18 | 19 |
Particulars | 10 years | 2011-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 21 | 105 | 133 | 175 | 70 | 143 | 251 | 155 | 70 | 134 | |
Cash Fr. Inv. | -76 | -107 | -99 | -107 | -74 | -62 | -33 | -72 | -150 | -164 | |
Cash Fr. Finan. | 53 | 1 | -33 | -68 | 4 | -80 | -215 | -81 | 92 | 17 | |
Net Change | -3 | -1 | 1 | 0 | 0 | 1 | 2 | 2 | 13 | -13 | |
Cash & Cash Eqvt | 5 | 4 | 5 | 3 | 3 | 5 | 7 | 9 | 22 | 8 |
Wed, 06 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate |
Wed, 29 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issue of Duplicate share certificate |
Fri, 24 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate |
Fri, 08 Dec 2023 |
|
|
|
|
|